Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Gynecologic and Obstetric Investigation|January 1, 1996
Effect of patient-derived lipids on in vitro expression of oncogenes by ovarian tumor cellsC Gercel-Taylor, D D TaylorOncology Reports|October 14, 1998
Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review)D D Taylor, C Gercel-TaylorMethods in Molecular Medicine|February 23, 2011
Use of diphenylamine in the detection of apoptosisR K Gibb, C Gercel-TaylorInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 26, 2002
Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignanciesK Dehaven, D D Taylor, C Gercel-TaylorObstetrics and Gynecology|April 24, 1999
Altered cord serum lipid levels associated with small for gestational age infantsJ N Jones, C Gercel-Taylor, D D TaylorJournal of Surgical Oncology|September 1, 1996
Modulation of colon tumor oncogene expression by cancer patient-derived lipidsD D Taylor, C Gercel-Taylor, J L WeeseJournal of the Society for Gynecologic Investigation|September 1, 1996
Expression and shedding of CD44 variant isoforms in patients with gynecologic malignanciesD D Taylor, C Gercel-Taylor, S A GallThe Journal of Surgical Research|January 1, 1996
Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cellsJ L Gwin, C Gercel-Taylor, D D Taylor, et al.Gynecologic Oncology|July 27, 1999
Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancerL B Bazzett, C S Watkins, C Gercel-Taylor, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 14, 2007
Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatmentS M Shondel, C W Helm, C Gercel-Taylor, et al.Pageof 2